发明名称 METHOD FOR TREATING MAMMARY GLAND CANCER
摘要 FIELD: medicine, oncology. ^ SUBSTANCE: during the first day of therapy it is necessary to affect the lesion focus with alternating magnetic field at induction being 5-160 mTl, frequency of 50-100 Hz for about 7-10 min. Out of peripheral vein one should sample blood into two vials with hemoconservant per 100 ml/each; one vial should be supplemented with doxorubicin at the dosage of 50 mg/sq. m, the second vial - with 5-fluorouracil 750 mg/sq. m. Both vials should be incubated. Then it is necessary to inject intravenously by drops the content of the first, and then of the second vial for a patient. During the period since the first day up to the seventh one it is necessary to introduce cyclophosphan intramuscularly per 200 mg/sq. m. Since the first up to the tenth day of therapy one should affect with alternating and direct magnetic field. On the eighth day after seances of magnetic therapy one should repeatedly introduce anti-tumor chemopreparations at the same dosages and sequence. In two weeks it is necessary to repeat the above-mentioned curative impacts. In two weeks after the last introduction of chemopreparations one should fulfill surgical removal of lesion focus. The innovation enables to avoid side toxic manifestations of chemopreparations and notching of sutures and, also, healing due to secondary tension. ^ EFFECT: higher efficiency of therapy. ^ 1 ex
申请公布号 RU2296593(C1) 申请公布日期 2007.04.10
申请号 RU20050126130 申请日期 2005.08.17
申请人 ROSTOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT MZ RF;SIDORENKO JURIJ SERGEEVICH;SALATOV RUSLAN NAURDINOVICH;BOSENKO EKATERINA SERGEEVNA 发明人 SIDORENKO JURIJ SERGEEVICH;SALATOV RUSLAN NAURDINOVICH;BOSENKO EKATERINA SERGEEVNA
分类号 A61N2/04;A61N2/06;A61P35/00 主分类号 A61N2/04
代理机构 代理人
主权项
地址